Ignite Creation Date:
2024-05-05 @ 9:08 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00819104
Status:
COMPLETED
Last Update Posted:
2009-09-09
First Post:
2009-01-07
Brief Title:
A Study to Compare the Efficacy Safety and Tolerability of Selomax With Its Individual Components
Sponsor:
AstraZeneca
Organization:
AstraZeneca